Apiaceae is a very big and cosmopolite family throughout the world and it is understood that majority of the worldwide species diversity is concentrated in Asia (some genera are exclusively Asiatic) and among them the genus
Ferulago W. Koch., which is represented by approximately 50 taxa throughout the world, is also found (
1-
3). The Asian countries with the greatest biodiversity are China, Turkey (Asiatic), Iran, Russia (Asiatic) and Kazakhstan (
2).
Ferulago species are known as “Çakşır” or “Çağşır” in Turkey (
3) and according to the recent records, the genus is represented by 35 taxa in Turkey, 18 of which are endemics (
4) and therefore Turkey is considered to be the gene center for the genus
Ferulago (
5). Though
Ferulago species have traditionally been used in the treatment of hemorrhoids, intestinal worms, against ulcers, snake bites, sickness and headaches and also as sedative, stimulant and digestive; they are mostly known for their aphrodisiac properties (
5-
6). In the light of their traditional uses, many biological activity studies have been performed and various
Ferulago species were found to possess cytotoxic (
7-
10), antimicrobial (
11-
14), antioxidant (
15-
18), immunomodulatory (
19-
20), antiangiogenic (
21), anti-inflammatory (
22) properties.
The results of biomedical research covering the last two decades years are quite in excess of information regarding the molecular events during carcinogenesis and potential signaling pathways involved in cancer progression. Recently many studies emphasizing anticancer, immunomodulatory, antiproliferative, antiapoptotic, cytotoxic activities of
Ferulago species against different tumor lines (
21-
27) have been published, therefore we aimed to investigate the antiproliferative effect of lyophilized extracts of
F. mughlae species on human prostate (PC-3) and colorectal (SW-480) carcinoma cells since cancer has become an important cause of morbidity and mortality in the world (
28).